Top Stories for the Week of June 11th 2007

Friday, June 15, 2007 07:44 AM

Top News

      
Private Equity Group Acquires Radiant Research to Grow the SMO Globally

Bellevue, Wash.-based Radiant Research, the largest owned-model site management organization (SMO) with 26 sites, has completed a sale of the business to an ownership group led by India-based ICICI Venture, a private equity company with $2 billion under management.

Veeda Clinical Research Acquires Phase I Unit in Germany

Veeda Clinical Research, an early phase contract research organization (CRO) with headquarters in both Plymouth, UK, and Ahmedabad, India, has bought a 40-bed phase I facility in Gorlitz, Germany. Financial and other details of the transaction were not disclosed; however, according to public records, the last company to own the unit was Medifacts International.

Other breaking news...      

Company Profile: An interview with Gary Velasquez, president and chief executive officer, Synarc.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs